SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses the implications of the company's recent Phase III trial failure for its Alzheimer's drug, with some investors expressing disappointment while others see it as an opportunity to buy. Despite the setback, there is optimism surrounding Novo Nordisk's position in the weight loss market, particularly with the potential upcoming approval of its oral Wegovy pill and comparison of CagriSema vs Zepbound study results.

Pony.ai, Inc. develops artificial intelligence-based robot designed for autonomous driving. The firm's software algorithms and infrastructure enables a vehicle to perceive its surroundings, predict what others will do, and maneuver itself accordingly. The company was founded by Jun Peng and Tian Cheng Lou in November 4, 2016 and is headquartered in Guangzhou, China.

Pony AI Inc. - ADR

Pony AI Inc

Pony AI is trending due to news of expanded robotaxi operations and partnerships, including a recent permit in Shanghai. The community is weighing the company's growth prospects against its financial performance, especially regarding profitability targets. Broader discussions involve comparing Pony AI to competitors in the autonomous driving space and assessing the impact of these developments on its market position.

Diginex Ltd. (Hong Kong) is a blockchain financial services and technology company. Its products include diginexESG, diginexLUMEN, diginexAPPRISE, diginexLUMEN Pro, and CSRD framework. The company was founded by Miles Christian Pelham on May 15, 2020 and is headquartered in London, the United Kingdom.

Diginex Ltd.

DGNX is trending due to its recent acquisition of The Remedy Project, sparking discussions about the company's expansion into human-rights remediation. The community is also actively analyzing potential trading strategies based on historical patterns of similar stocks. Options traders are closely monitoring put contracts, anticipating potential downside amidst the volatility.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending due to strong Q3 2025 earnings, highlighted by a 144.3% YoY revenue increase and significant growth in robotaxi revenue, with community members noting global expansion and regulatory milestones in the UAE and Switzerland. Investors are focused on WeRide's progress toward deploying hundreds of thousands of robotaxis by 2030 and its partnerships with companies like Bosch, Uber, and Grab. The conversation also includes comparisons to competitor Pony.ai, whose stock performance and institutional ownership are being weighed against WeRide's recent gains and expansion efforts.

Monad

Monad is trending as users discuss its upcoming launch and token distribution, particularly excitement around receiving tokens from the Coinbase presale. The community is actively speculating on potential price movements and strategies, with some comparing it to other recent launches. There's also discussion around the mainnet launch date.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending amid mixed sentiment, as discussions range from its ties to controversial figures to its evolving stance on cryptocurrency and potential competition with Bitcoin. The community is actively debating JPMorgan's investment strategies, alleged market manipulation, and the implications of its exploration of blockchain technology and stablecoins. Additionally, some traders are monitoring technical indicators to predict JPM's short-term price movements, while others are discussing potential investigations and regulatory scrutiny.

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Alvotech

Alvotech ($ALVO) is trending following the announcement of European approval for AVT03, a biosimilar to Prolia and Xgeva, used in bone disease treatment, sparking bullish sentiment. Despite some community concerns about cash flow and previous manufacturing setbacks, the biosimilar's approval and analyst upgrades are fueling optimism. Discussions center on the company's potential in the biosimilar market and strategic partnerships.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending as the stock price rises following news of its AI integration with Open AI, which is expected to enhance merchant and customer experiences, with some analysts predicting a significant price target increase. However, some community members are skeptical about the sustainability of Shopify's growth, citing competition and valuation concerns, while others point to the company's strong position in the e-commerce sector and potential for further gains.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi-Aventis ($SNY) is trending amid speculation surrounding potential acquisitions, particularly in the MASH and obesity spaces, with $ALT, $GUTS, and $IVA being mentioned as possible targets. Community discussions revolve around the company's pipeline expansion needs and potential partnerships, with some users highlighting data integrity concerns around one of the speculated targets. The broader context involves Sanofi's strategic moves to strengthen its immunology and vaccine portfolio.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

MFI is trending due to its recent $500M private placement aimed at building a Bitcoin Cash treasury, fueling speculation about a potential pivot into crypto equity. Community members are discussing the involvement of a Chinese billionaire and the possibility of MFI becoming a major player in the crypto space. The stock's volatile price action and small float are contributing to the heightened interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of PMGC Holdings Inc. jumped 230% in early premarket trading on Tuesday, drawing significant interest from Stocktwits members.Message volume for the ticker on Stocktwits rose a whopping 7,400% in the last 24 hours, and the sentiment reading shifted to 'extremely bullish' as of early Tuesday from 'bullish' the previous day.There was no apparent catalyst for the stock, although several users said they had the ticker on their watchlist.&nbsp;<figure class="image"><img style="aspect-ratio:571/79;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_1_17_11_PM_png_0063eedc3a.webp" alt="Screenshot 2025-10-14 at 1.17.11 PM.png" width="571" height="79"><figcaption>ELAB sentiment and message volume as of October 14 | Source: Stocktwits</figcaption></figure>PMGC Holdings, which changed its name from Elevai Labs Inc. and also redomiciled from Delaware to Nevada in December 2024, is a U.S.-based holding firm. The company, through its subsidiaries, focuses on cutting-edge aesthetic medicines and therapeutic products for skin aesthetics, obesity, and metabolic health.Its main product, EL-22, is an engineered probiotic designed to help prevent muscle loss during weight loss treatments, such as those using GLP-1 drugs.So far this year, PMGC has approached at least two companies — one manufacturing high-precision parts for the aerospace and defense sectors, and another packing solutions firm — for acquisitions.In August, the company implemented a one-for-3.5 reverse stock split of its common stock.Year-to-date,&nbsp;<a href="https://stocktwits.com/symbol/ELAB">ELAB shares</a> are down 90.7% on a split-adjusted basis. The company had a market cap of $3.5 million as of the stock's last close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aka-stock-soars-over-40-after-hours/ch6mi41R3ls">AKA Stock Soars Over 40% After-Hours, Draws Interest From Retail Traders</a>

Traders work on the floor of the New York Stock Exchange during morning trading on September 17, 2025, in New York City. 

PMGC Holdings Stock Jumps 230% Premarket, Grabs Retail Eyeballs

Earlier known as Elevai Labs, PMGC turned into a holding company last year.

Equity

Earlier known as Elevai Labs, PMGC turned into a holding company last year.


Shares of PMGC Holdings Inc. (ELAB) surged over 25% on Monday morning after the company inked a non-binding letter of intent to acquire a U.S. electronics contract manufacturing firm with a four-decade operational track record.This marks PMGC’s second acquisition initiative since April. The agreement pertains to a privately held firm specializing in high-accuracy electronics manufacturing.&nbsp;The target company’s capabilities include assembling electrical and mechanical components, producing printed circuit boards, conducting electronic component evaluations, and offering prototyping services.&nbsp;In 2024, the target company reported approximately $699,000 in revenue and an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of around $173,000.With this latest step, PMGC aims to expand its holdings by acquiring financially sound enterprises recognized for their reliable earnings and growth potential.&nbsp;PMGC executives noted that the acquisition target is distinguished by its efficient operations and long-standing partnerships within the commercial and industrial electronics markets.This acquisition aligns with a broader resurgence in U.S.-based manufacturing, fueled by government initiatives like the CHIPS and Science Act.&nbsp;Enacted on Aug. 9, 2022, the bipartisan CHIPS and Science Act seeks to revitalize the U.S. semiconductor sector while strengthening the country’s research and innovation ecosystem.&nbsp;The legislation allocates $52.7 billion in federal support to initiatives such as building new chip fabrication plants, advancing research and development efforts, and enhancing workforce training.&nbsp;As more supply chains shift back to domestic production, demand for American electronics manufacturers is on the rise.PMGC views this transaction as a timely opportunity to tap into that growing momentum.On Stocktwits, retail sentiment around PMGC changed to ‘extremely bullish’ from ‘bearish’ the previous day.<figure class="image"><img style="aspect-ratio:958/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_102350_png_3369427ecd.webp" alt="PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits" width="958" height="104"><figcaption>PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed optimism on the shares.<stembedurl>https://stocktwits.com/cjstocksup/message/617252666</stembedurl> <a href="https://stocktwits.com/symbol/ELAB">PMGC</a> stock has lost over 82% in 2025 and over 99% in the last 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/leddar-tech-extends-credit-and-loan-terms-welcomes-back-employees/chlEWXwRby9">LeddarTech Stock Jumps As Company Announces Amended Loan Terms: Retail Stays On The Sidelines</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure

PMGC views the transaction as a timely opportunity, as demand for American electronics manufacturers is on the rise, with more supply chains shifting back to domestic production.

Shares of PMGC Holdings Inc. (Elab) surged more than 50% on Friday as the skin care and biopharma products company said its subsidiary plans to present a probiotic-based weight loss treatment, sparking retail chatter.PMGC, formerly Elevai Labs, said its subsidiary Northstrive Biosciences was invited to present at an upcoming symposium called Anti-Obesity Treatments: Challenges and Emerging Solutions organized by UCLA Metabolism Theme, the company said.This symposium is targeted at obesity-focused clinicians, researchers, drug developers and investors to address the challenges brought up by weight loss treatments.Northstrive Biosciences’ EL-22 product is a probiotic approach for preserving muscle while on weight loss treatments, said the company. Northstrive’s EL-22 is being developed as a potential combination therapy with GLP-1 receptor agonists for preserving muscle while on weight loss treatments. According to studies, about 30-50% of body weight lost with GLP-1 based therapy is lean muscle mass, a common side effect.<stembedurl>https://stocktwits.com/DumbMoneyDoji/message/601529726</stembedurl><stembedurl>https://stocktwits.com/Schizoo/message/601513712</stembedurl>“The rise of anti-obesity medications has put the spotlight on the challenges being faced, particularly the management of muscle and bone loss associated with GLP-1 receptor agonists,” Orian Shirihai, Director of UCLA’s Metabolism Theme, said. “We organized this event to gather obesity’s leading opinion leaders to review the gaps and highlight the emerging solutions.”Last month, PMGC underwent a ‘strategic reorganization’ that included a name change to PMGC Holdings and redomiciling from Delaware to Nevada, in an effort to ‘streamline operations and create a more efficient legal and governance framework.”PMGC specializes in medical aesthetics and biopharmaceuticals with its subsidiaries across skincare, biosciences, research, among others.PMGC stock is up 35% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

PMGC Stock Surges On Invitation To Present ‘Probiotic’ For Preventing Muscle Loss: Retail Chatter Spikes

Its product, EL-22, is a probiotic approach for preserving muscle while on weight loss treatments

Shares of Elevai Labs Inc. ($ELAB) rose 8% on Friday after the operator of skin care product companies announced a ‘strategic reorganization’ including a name change to PMGC Holdings and redomiciling from Delaware to Nevada, drawing a mixed reaction from retail investors on Stocktwits. After this reorganization, Elevai, which specializes in medical aesthetics and biopharmaceuticals, will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.” The redomestication and name change will go into effect on Nasdaq at the opening of business on December 23, the company said.According to a company statement, the company will focus on enhancing operational efficiencies across its existing entities and pursue ‘synergistic acquisitions’ and also consider ‘strategic divestitures’ of assets that are underperforming or do not align with its long-term strategy. Its decision to redomicile from Delaware to Nevada aligns with its “mission to streamline operations and create a more efficient legal and governance framework,” it added, noting legal benefits such as a business-friendly regulatory environment and potential for long-term cost savings as a result of lower state tax obligations.Retail rection on Stocktwits was a mixed bag.<stembedurl>https://stocktwits.com/CatchingCrumbs/message/597432218</stembedurl><stembedurl>https://stocktwits.com/Chester_Copperpot85/message/597445584</stembedurl>Elavai’s portfolio consists of four wholly owned subsidiaries: Elevai Skincare Inc., Elevai Biosciences Inc., Elevai Research Inc., and PMGC Capital LLC.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Elevai Labs Announces Name Change to PMGC Holdings: Retail’s Cautious

After this reorganization, Elevai will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.”

The S&amp;P 500 retreated from its closing high (6,001.35) hit on Monday before ending the week at 5,870.62, down 2.08% for the 5-session period. Techs suffered steep losses, as evident from the 3.15% pullback by the Nasdaq Composite Index. The 30-stock Dow Jones Industrial Average was down a more modest 1.24%.As the rally stalled and the broader market experienced its steepest weekly losses since early September, the following stocks were the most active on the Stocktwits platform (based on message volume):<ul><li>Dogecoin (<a class="mention" data-mention="$DOGE.X" data-symbol-id="DOGE.X" href="https://stocktwits.com/symbol/DOGE.X" target="_blank">$DOGE.X</a>)</li><li>Bitcoin (<a class="mention" data-mention="$BTC.X" data-symbol-id="BTC.X" href="https://stocktwits.com/symbol/BTC.X" target="_blank">$BTC.X</a>)</li><li>Tesla, Inc. (<a class="mention" data-mention="$TSLA" data-symbol-id="TSLA" href="https://stocktwits.com/symbol/TSLA" target="_blank">$TSLA</a>)</li><li>Super Micro Computer, Inc. (<a class="mention" data-mention="$SMCI" data-symbol-id="SMCI" href="https://stocktwits.com/symbol/SMCI" target="_blank">$SMCI</a>)</li><li>Ripple (<a class="mention" data-mention="$XRP.X" data-symbol-id="XRP.X" href="https://stocktwits.com/symbol/XRP.X" target="_blank">$XRP.X</a>)</li><li>SPDR S&amp;P 500 ETF Trust (<a class="mention" data-mention="$SPY" data-symbol-id="SPY" href="https://stocktwits.com/symbol/SPY" target="_blank">$SPY</a>)</li><li>Autozi Internet Technology Global Ltd. (<a class="mention" data-mention="$AZI" data-symbol-id="AZI" href="https://stocktwits.com/symbol/AZI" target="_blank">$AZI</a>)</li><li>Trump Media &amp; Technology Group Corp. (<a class="mention" data-mention="$DJT" data-symbol-id="DJT" href="https://stocktwits.com/symbol/DJT" target="_blank">$DJT</a>)</li><li>GameStop Corp. (<a class="mention" data-mention="$GME" data-symbol-id="GME" href="https://stocktwits.com/symbol/GME" target="_blank">$GME</a>)</li><li>Elevai Labs, Inc. (<a class="mention" data-mention="$ELAB" data-symbol-id="ELAB" href="https://stocktwits.com/symbol/ELAB" target="_blank">$ELAB</a>)</li></ul>Dogecoin: Riding on the crypto rally following Donald Trump’s victory in the 2024 presidential election, Dogecoin rallied to a high of $0.435863 on Tuesday pulling back to a low of $0.354469 three sessions later.&nbsp;A poll&nbsp; to solicit opinion from Stocktwits users regarding the year-end price target for Doge, which has an hour left for closing, showed about 41% think it would end 2024 between $0.50 and $1.00.&nbsp;A Stocktwits user said the rally could resume if rumors of the incoming Trump administration eliminate capital gains taxes on U.S.-issued cryptocurrencies.&nbsp;<stembedurl>https://stocktwits.com/Gainz4dayss/message/592967020</stembedurl>Bitcoin:&nbsp;Bitcoin, which is the top crypto by market capitalization, broke above $80K last Sunday and climbed to an intraday high of $93,434.35 on Wednesday. Since then, the Bitcoin rally has cooled off amid the stock market weakness.&nbsp;Bullish investors and analysts are eyeing a break above the $100,000 mark.&nbsp;Stocktwits users are mostly positive, with one user suggesting the technical chart looks “pretty solid.”<stembedurl>https://stocktwits.com/MainlyAlright/message/592966996</stembedurl>Tesla:&nbsp;The extended rally in the shares of Elon Musk-led electric-vehicle company Tesla stalled last week. After scaling an intraday high of $358.64 and a closing high of $350 on Monday, the stock has pulled back sharply. For the week, Tesla shares lost 0.16%, although they shed a steeper 10.57% from the intraday highs.&nbsp;Tesla bull and the Future Fund LLC Managing Partner Gary Black recently trimmed his Tesla position, reasoning that Tesla at $350 is less attractive than Tesla at $140.Super Micro: Embattled artificial intelligence server maker Super Micro fell in the first four sessions of the week amid fears of potential delisting. The company delayed the filing of its annual report for the fiscal year 2024 and also its first quarter of the next fiscal that ended on Sept. 30, 2024.&nbsp;The company received some good tidings late in the week when three broker-dealers with common ownership acquired 30.83 million shares of the company, translating to a 5.3% stake.The unfolding week is important as investors await word on the company’s response to the deadline for filing its annual report.Ripple: Payments cryptocurrency XRP crossed the $1 threshold on Saturday for the first time in three years. The crypto’s strength is attributable to the expectations that the incoming Trump administration will formulate pro-crypto policies.&nbsp;Ripple has been the subject of an investigation by the SEC after the blockchain company raised more than $1.3 billion in 2013 by selling XRP in an unregistered public offering. The SEC has an ongoing lawsuit against Ripple in the U.S.&nbsp;Southern District Court of New York.The widespread expectation is that SEC Chair Gary Gensler, who has been tough with cryptocurrency companies, could step down soon as part of the new guard taking over on the political arena.&nbsp;SPY:&nbsp;Following the market pullback, SPY garnered some attention and was among the active sought out security on Stocktwits last week. The upcoming week is crucial for the SPY, as Nvidia - a heavily weighted stock, is scheduled to report earnings. The artificial intelligence stalwart’s earnings have ramifications for a slew of heavily-weighted tech stocks pursuing AI.&nbsp;Some key economic data due for the unfolding week include S&amp;P Global’s private sector activity readings for November, the Conference Board’s leading economic index for October, the weekly jobless claims data and a few housing market readings. The market participants may also stay tuned to a spate of Fed speeches scheduled for they week as they worry about the rate trajectory.Autozi:&nbsp;Chinese automotive products and services company Autozi was in the news last week amid news of increased institutional interest in the company. Message volume for the stock spiked higher, with most on Stocktwits ‘bullish’ on the stock.&nbsp;The company followed up with the two 13G filings on Wednesday, and filed yet another on Friday in which it disclosed CEO&nbsp;Houqi Zhang has hiked his stake to 40.6% of the Class A shares, assuming conversion of the Class B ordinary shares owned by him.&nbsp;Trump Media: The post-election bump received by Trump-controlled Trump Media &amp; Technology stock cooled off last week. The owner of Truth Social platform continues to be viewed positively by the retail.&nbsp;GameStop:&nbsp;Meme stock GameStop, a retailer of video games, saw volatility in the week ended Nov. 15. It, however, bucked the broader market weakness and ended the week up by 6.87%.&nbsp;Elevai Labs:&nbsp;Newport Beach, California-based Elevai, a skincare development company, was in the news over the release of its fiscal year second-quarter results last week. Retailers on Stockwits are hoping for a short-squeeze, with 19.08% of the outstanding shares held short.&nbsp;Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/trip.com-earnings-for-q3-2024-due-after-the-market-close-monday/cJ4HsezRQ2">Trip.com Analysts Optimistic Amid Robust Travel Trends In China As Stock Looks To Extend Strong Gains For Year</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

The broader market pulled back last week amid a few strong data and hawkish Fed commentary. | Photo Courtesy of Wikimedia Commons

10 Most Active Stocks On Stocktwits Last Week With Message Volume Spurt 

Cryptocurrencies, stocks that pulled back from their post-election highs, and some obscure securities were among those that saw huge message volumes in the past week.

Dow Gains Over 50 Points; Elevai Labs Shares Plummet

ELEVAI Labs Shares Future Direction and Financial Outlook

ELEVAI Labs Inc. (ELAB) has shared an announcement.

Elevai Labs Inc. has initiated the distribution of a key presentation to the investment community, showcasing a summary of their direction and...

Elevai Labs reports Q4 revenue $698,591 vs. $554,654 in Q3

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Elevai Labs reports Q4 results

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results

Company reports record annual revenues of $1.71 Million for 2023, up 123.5% over the previous year Company reports record Q4 2023 revenues of $698,591, up 403% from Q4 2022 NEWPORT BEACH, Calif...

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

ELAB
PMGC Holdings Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELAB News

ELABPMGC Holdings Inc.